|Day Low/High||66.14 / 66.92|
|52 Wk Low/High||62.70 / 84.88|
The prices of generic drugs are declining as more of them are becoming available on the market along with pressure from major retail pharmacies.
Consolidation, improving equity prices and sufficient firepower for deals continue to fuel med tech M&A, according to EY's Jeff Greene.
The labor market goes under inspection and Apple releases its earnings report.
McCaskill requested that four more drug companies and three drug distributors turn over documents.
McKesson faced some opposition at its shareholder meeting from an unconventional activist investor—a labor union.
ISS and Glass, Lewis echo the union's call for management to address the drug distributor's role in the opioid crisis.
Through a new grant program, Generation Rx supports healthcare systems in the mission to reduce the risk of opioid overdose and dependency
State-backed Chinese pharmaceutical companies have shown interest.
The most recent short interest data has been released for the 06/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
Edison International, Cardinal Health among stocks going ex-dividend next week.
The main thrust of the order appears to be easing regulatory hurdles to drug approvals, which could lower the cost of bringing new treatments to market and thus lower prices.
Generic drugmakers are likely to limit themselves to acquisitions of small- and mid-sized companies in the immediate future because of over-leveraging and turmoil in the executive ranks..
Oncologists express lack of confidence in MACRA, growing interest in real-world evidence
Jim Cramer discusses the rebound and also mentions the best tech story that no one knows about.
Here are Wednesday's top research calls, including new coverage of Advanced Micro Devices and Transocean, upgrades for Clovis Oncology and ConocoPhillips, and a downgrade for Disney.
Medtronic, J&J and Cardinal Health appear poised to benefit from an aging U.S. population, say investment experts.
Jennifer Dawson received award and $25,000 educational grant to Texas State University on behalf of Cardinal Health
Wall Street ended its first session of May mostly higher as tech stocks boosted the Nasdaq and a congressional funding deal brought relief to the S&P 500.
Stocks are mostly higher on Monday after congressional leaders reach a deal to fund the federal government through the rest of the budget year.
The Cordis and Medtronic acquisitions are meant to shield Cardinal from the pricing swings of drug distribution.
Stocks turn green again on Monday morning after congressional leaders reach a deal to fund the federal government through the rest of the budget year.
Stock futures rise on Monday after congressional leaders reach funding deal to avoid a government shutdown.